Company Profile

Gracell Biotechnologies Inc. (NASDAQ: GRCL)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 0.00
% Price Change (last 13 weeks): 0.00
% Price Change (last 26 weeks): 1.49
% Price Change (last 52 weeks): 167.28
% Price Change (year to date): 2.09
Management Effectiveness
Return on Equity (%): -37.23
Return on Assets (%): -32.14
Return on Invested Capital (%): -38.19
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $n/a
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): n/a
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.
Gracell Biotechnologies Inc.
Biobay & Suzhou Industrial Park 218 Sangtian Street Building 12, Block B, Phase II
Suzhou SH 215123

Phone: 86.512.6262.6701
Fax: n/a
http://www.gracellbio.com
Per Share Data
Earnings (1year) ($): -1.02
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 2.92
Cash Flow ($): -1.20
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 0.79
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 6.78
Current Ratio (x): 6.78
LT Debt/Equity (x): 3.85
Total Debt/Equity (x): 13.30



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.